Vital Biopharmaceutical Insights and Analytics

for Experts from Experts

Decision Resources is the premier provider of analysis and data on the significant issues facing the biopharmaceutical industry.

Learn More

Search Reports

TOP TEN REPORTS

See which reports have been searched on the most.

Go

In the Spotlight

Join us in New York

This exciting one-day seminar provides attendees with a unique opportunity to hear in-depth analysis of hot topics and trends concerning global biosimilars while engaging directly with Decision Resources Group analysts.

View the Agenda  |  Meet our expert speakers

Register

 


Recent Reports [ view all ]

  • Physician Perspectives on Erythropoiesis-Stimulating Agents, Insulin, and Human Growth Hormone

    Nephrologists and endocrinologists in Europe have had the opportunity to use biosimilar erythropoiesis-stimulating... Read More

  • Prostate Cancer - 2014

    Last Updated 24 October 2014
    The prostate cancer market has witnessed considerable changes over the... Read More

  • Oral HIF-PH Inhibitors for the Treatment of Renal Anemia in CKD Non-Dialysis and Dialysis: How Will U.S. Physicians and Payers Respond to This Novel Class?

    Renal anemia and hyperphosphatemia, or elevated serum phosphorous, are two primary complications of chronic kidney... Read More

Decision Resources Group brands include: